Robin Lachmann

165 papers receiving 8.8k citations

Robin Lachmann's Hit Papers

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis 2018 · 278 citations
2780+5+11Years since publication250500750

Peers

Robin Lachmann
Comparison fields: 5 of 122
  • Clinical Biochemistry 1.1k
  • Physiology 3.8k
  • Nephrology 664
  • Neurology 433
  • Radiology, Nuclear Medicine and Imaging 505
Replace Philip John Lee with:
Philip John Lee United Kingdom
Dominique Paul Germain France
Atul B Mehta United Kingdom
Michael Beck Germany
Joel Charrow United States
Vassili Valayannopoulos France
Masafumi Matsuo Japan
Maria Alice Donati Italy
Yin‐Hsiu Chien Taiwan
Rossella Parini Italy
Robin Lachmann relative to Philip John Lee United Kingdom Philip John Lee's profile →
Citations per field
00.5×2×3×4.3×
Philip John Lee · 1×
Citations per year

Countries citing papers authored by Robin Lachmann

Since Specialization
Citations

This map shows the geographic impact of Robin Lachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Lachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Lachmann more than expected).

Fields of papers citing papers by Robin Lachmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Lachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Lachmann. The network helps show where Robin Lachmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Lachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Lachmann Line = papers co-authored together Robin Lachmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2010780
2 2000633
3
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Hit paper breakdown →
2009595
4
Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping
Hit paper breakdown →
2013412
5 2016310
6 2015297
7 2012284
8
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Hit paper breakdown →
2018278
9 2004205
10 2015200
11 2014162
12 2019134
13 2016133
14 2017132
15 2004130
16 2018128
17 2004126
18 2011115
19 2018112
20 2012104

About Robin Lachmann

Robin Lachmann is a scholar working on Clinical Biochemistry, Physiology, Nephrology, Rheumatology and Epidemiology, having authored 174 papers that have together received 9.1k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (87 papers), Metabolism and Genetic Disorders (41 papers), Parathyroid Disorders and Treatments (11 papers), Glycogen Storage Diseases and Myoclonus (9 papers), Herpesvirus Infections and Treatments (9 papers), Virus-based gene therapy research (6 papers), Advanced MRI Techniques and Applications (3 papers) and Hereditary Neurological Disorders (2 papers). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Physiology (3.8k citations), Nephrology (664 citations), Neurology (433 citations) and Radiology, Nuclear Medicine and Imaging (505 citations). Robin Lachmann has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Elaine Murphy, Frances M. Platt, Derralynn A. Hughes, Timothy Martin Cox, Stacey Efstathiou, Terry D. Butters, Raymond Allen Dwek, Carla E. M. Hollak, Atul B Mehta and Perry Mark Elliott. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Orphanet Journal of Rare Diseases, The Lancet and Neuromuscular Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact